Stockreport

Vafseo® approved by the U.S. FDA for the treatment of anemia due to chronic kidney disease in dialysis-dependent adult patients [Yahoo! Finance]

Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share)  (FMS) 
Last fresenius medical care ag american depositary shares (each representing 1/2 of an ordinary share) earnings: 7/31 04:03 pm Check Earnings Report
PDF Food and Drug Administration (FDA) has approved Vafseo (vadadustat) tablets for the treatment of anemia due to chronic kidney disease (CKD) in adults who have been recei [Read more]